Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review

Background: There is a belief that in patients with acromegaly, first-generation somatostatin analogs (SSAs) might improve cardiovascular (CV) structure and function. However, most published clinical trials involved only a few patients and their results are rather variable. We aimed to conduct a sys...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Maryam Heidarpour, Davood Shafie, Ashraf Aminorroaya, Nizal Sarrafzadegan, Ziba Farajzadegan, Rasool Nouri, Arash Najimi, Christina Dimopolou, Gunter Stalla
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2019-01-01
Serija:	Journal of Research in Medical Sciences
Teme:	acromegaly cardiomyopathy growth hormone receptor somatostatin
Online dostop:	http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=29;epage=29;aulast=Heidarpour
Oznake:	Označite Brez oznak, prvi označite!